查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553660

戒菸與尼古丁成癮市場規模、佔有率、趨勢分析報告：按類型、形式、分銷管道、地區、細分市場預測，2024-2030

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

戒菸和脫尼古丁成癮市場的成長和趨勢：

Grand View Research, Inc.的研究報告顯示，到2030年，全球戒菸和尼古丁成癮市場規模預計將達到509億美元，2024年至2030年複合年成長率為10.4%。

世界各地吸煙成癮的人數正在迅速增加。此族群主要包括青少年和勞動人口。吸菸造成的死亡率非常高。日益成長的戒菸願望以及與吸菸相關的許多健康併發症是公司推出創新戒菸產品的強大動力，例如Revolmar，該公司推出了下一代尼古丁口香糖來幫助吸菸者戒菸。這種改進和創新的尼古丁替代療法產品的推出將成為戒菸和尼古丁成癮市場成長的有力推動力。

慢性阻塞性肺病（COPD）、氣喘、心臟疾病和肺癌等目標疾病的盛行率不斷上升，以及對吸菸有害副作用的認知不斷提高，預計將推動市場擴張。教育機構正在積極開展各種宣傳活動和方案，傳播有關吸煙有害影響和後果的訊息，提高年輕人的認知。

戒菸和脫尼古丁成癮市場報告亮點

  • 尼古丁替代療法（NRT）在 2023 年的戒菸和去尼古丁成癮產品市場中佔據主導地位。常用的NRT產品包括尼古丁口香糖和經皮吸收貼片。可用性的增加和各種口味的可攝取尼古丁產品的推出是獲得巨大市場佔有率的因素。
  • 預計電子煙產業在預測期內將以 8.48% 的複合年成長率成長。電子煙市場成長的主要因素是第二代和第三代電子煙的推出、各種口味產品的供應、眾多以不同品牌經營和銷售電子煙的供應商的存在等。
  • 2023年，北美佔據成癮和尼古丁戒斷市場佔有率的40.3%。
  • 亞太地區是成長最快的地區。尼古丁戒菸產品和電子煙在中國、印度和澳洲等國家的註冊以及企業分銷管道的加強將支持預測期內的成長。
  • 市場參與者透過專注於 FDA核准的尼古丁產品的市場開拓、商業化和分銷，在電子煙市場取得緩慢但穩定的進展。例如，勝利電子煙公司於2014年收購了十動機有限公司，旨在擴大銷售管道並獲得更廣泛的市場覆蓋範圍。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 戒菸和戒除尼古丁成癮的市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 戒菸與脫尼古丁成癮市場分析工具
    • 波特的分析
    • PESTEL分析
    • 政局
    • 經濟和社會狀況
    • 技術景觀
    • 環境狀況
    • 法律狀況

第 4 章：戒菸和戒除尼古丁成癮市場：按類型估計和趨勢分析

  • 細分儀表板
  • 尼古丁替代療法
  • 藥物治療
  • 電子煙

第5章戒菸和戒除尼古丁成癮市場：按表格類型的估計和趨勢分析

  • 細分儀表板
  • 戒菸與脫尼古丁成癮市場：2023 年和 2030 年按形式類型變化分析
  • 膠
  • 吸入器
  • 藥片
  • 其他

第6章戒菸和尼古丁戒斷成癮：按分銷管道類型進行估計和趨勢分析

  • 細分儀表板
  • 戒菸與脫尼古丁成癮市場：2023 年和 2030 年按通路類型分類的波動分析
  • 醫院藥房
  • 線上
  • 藥局和藥房

第7章吸煙吸煙和脫尼古丁成癮市場：區域估計和趨勢分析

  • 2023 年和 2030 年戒菸和脫尼古丁成癮市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Rusan Pharma Ltd
    • Dr. Reddy's Laboratories Ltd
    • Imperial Brands Plc
    • Zydus Group.
    • British American Tobacco Plc
    • Perrigo Company Plc
    • Johnson and Johnson Inc
    • NJOY, LLC
    • Cipla Ltd
    • GlaxoSmithKline Plc.
簡介目錄
Product Code: 978-1-68038-908-1

Smoking Cessation And Nicotine De-addiction Market Growth & Trends:

The global smoking cessation and nicotine de-addiction market size is expected to reach USD 50.90 billion by 2030, growing at a CAGR of 10.4% from 2024 to 2030, according to a report by Grand View Research, Inc. The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Smoking Cessation And Nicotine De-addiction Market Report Highlights:

  • Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2023. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.
  • The e-cigarette segment is anticipated to grow at a CAGR of 8.48% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.
  • North America dominated the smoking cessation and nicotine de-addiction market with a market share of 40.3% in 2023.
  • Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period.
  • The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Smoking Cessation and Nicotine De-addiction Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Smoking Cessation and Nicotine De-addiction Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1 Bargaining power of the suppliers
      • 3.4.1.2 Bargaining power of the buyers
      • 3.4.1.3 Threats of substitution
      • 3.4.1.4 Threats from new entrants
      • 3.4.1.5 Competitive rivalry
    • 3.4.2. PESTEL Analysis
    • 3.4.3 Political landscape
    • 3.4.4 Economic and Social landscape
    • 3.4.5 Technological landscape
    • 3.4.6 Environmental landscape
    • 3.4.7 Legal landscape

Chapter 4. Smoking Cessation and Nicotine De-addiction Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nicotine Replacement Therapy
    • 4.2.1. Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2 Nicotine Lozenges
      • 4.2.2.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3 Nicotine Gums
      • 4.2.3.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4 Nicotine Sprays
      • 4.2.4.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5 Nicotine Inhalers
  • 4.3. Drug Therapy
    • 4.3.1. Drug Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. E-cigarettes
    • 4.4.1. E-cigarettes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Smoking Cessation and Nicotine De-addiction Market: Form Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Smoking Cessation and Nicotine De-addiction Market: Form Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Gum
    • 5.3.1. Gum Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Inhalers
    • 5.4.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Tablets
    • 5.5.1. Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Online
    • 6.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Drug stores and Retail Pharmacies
    • 6.5.1. Drug stores and Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Smoking Cessation and Nicotine De-addiction Market : Regional Estimates & Trend Analysis

  • 7.1. Smoking Cessation and Nicotine De-addiction Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1 U.S. Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1 Canada Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1 Mexico Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1 UK Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1 Germany Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1 France Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1 Italy Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1 Spain Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1 Denmark Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1 Sweden Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1 Norway Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1 Japan Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1 China Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1 India Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1 Australia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1 South Korea Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1 Thailand Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1 Brazil Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1 Argentina Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1 South Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1 Saudi Arabia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1 UAE Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1 Kuwait Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Rusan Pharma Ltd
      • 8.4.1.1 Participant's Overview
      • 8.4.1.2 Financial Performance
      • 8.4.1.3 Product Benchmarking
      • 8.4.1.4 Recent Developments/ Strategic Initiatives
    • 8.4.2. Dr. Reddy's Laboratories Ltd
      • 8.4.2.1 Participant's Overview
      • 8.4.2.2 Financial Performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Recent Developments/ Strategic Initiatives
    • 8.4.3. Imperial Brands Plc
      • 8.4.3.1 Participant's Overview
      • 8.4.3.2 Financial Performance
      • 8.4.3.3 Product Benchmarking
      • 8.4.3.4 Recent Developments/ Strategic Initiatives
    • 8.4.4. Zydus Group.
      • 8.4.4.1 Participant's Overview
      • 8.4.4.2 Financial Performance
      • 8.4.4.3 Product Benchmarking
      • 8.4.4.4 Recent Developments/ Strategic Initiatives
    • 8.4.5. British American Tobacco Plc
      • 8.4.5.1 Participant's Overview
      • 8.4.5.2 Financial Performance
      • 8.4.5.3 Product Benchmarking
      • 8.4.5.4 Recent Developments/ Strategic Initiatives
    • 8.4.6. Perrigo Company Plc
      • 8.4.6.1 Participant's Overview
      • 8.4.6.2 Financial Performance
      • 8.4.6.3 Product Benchmarking
      • 8.4.6.4 Recent Developments/ Strategic Initiatives
    • 8.4.7. Johnson and Johnson Inc
      • 8.4.7.1 Participant's Overview
      • 8.4.7.2 Financial Performance
      • 8.4.7.3 Product Benchmarking
      • 8.4.7.4 Recent Developments/ Strategic Initiatives
    • 8.4.8. NJOY, LLC
      • 8.4.8.1 Participant's Overview
      • 8.4.8.2 Financial Performance
      • 8.4.8.3 Product Benchmarking
      • 8.4.8.4 Recent Developments/ Strategic Initiatives
    • 8.4.9. Cipla Ltd
      • 8.4.9.1 Participant's Overview
      • 8.4.9.2 Financial Performance
      • 8.4.9.3 Product Benchmarking
      • 8.4.9.4 Recent Developments/ Strategic Initiatives
    • 8.4.10. GlaxoSmithKline Plc.
      • 8.4.10.1 Participant's Overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product Benchmarking
      • 8.4.10.4 Recent Developments/ Strategic Initiatives